F543-0605 Screening compound: N-{1-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl}benzenesulfonamide

F543-0605 Screening compound: N-{1-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl}benzenesulfonamide
F543-0605 Screening compound: N-{1-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl}benzenesulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F543-0605
N-{1-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl}benzenesulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F543-0605

Molecular Formula

C24H27N5O4S (C24 H27 N5 O4 S)

Compound Name

N-{1-[3-(1-cyclopentyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)-1,2,4-oxadiazol-5-yl]-2-methylpropyl}benzenesulfonamide

IUPAC name

N-{1-[3-(1-cyclopentyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl)-124-oxadiazol-5-yl]-2-methylpropyl}benzenesulfonamide

SMILES

CC(C)C(c1nc(-c(cc2)cc(N3)c2N(C2CCCC2)C3=O)no1)NS(c1ccccc1)(=O)=O

InChI

InChI=1S/C24H27N5O4S/c1-15(2)21(28-34(31,32)18-10-4-3-5-11-18)23-26-22(27-33-23)16-12-13-20-19(14-16)25-24(30)29(20)17-8-6-7-9-17/h3-5,10-15,17,21,28H,6-9H2,1-2H3,(H,25,30)/t21-/m0/s1

InChI Key

ORJXFNHTOUGQPG-NRFANRHFSA-N

MDL Number (MFCD)

MFCD27175290

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.58

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.785

Distribution Coefficient, logD

5.705

Water Solubility, LogSw

-5.41

Polar Surface Area

99.651

Acid Dissociation Constant (pKa)

8.10

Base Dissociation Constant (pKb)

-1.22

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

37.50

F543-0605 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Lipid Metabolism Library (9174 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F543-0605 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F543-0605?
Check Price and Availability of F543-0605, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F543-0605 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F543-0605
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F543-0605
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F543-0605 available by request